Ohio Public Employees Retirement System (OPERS)’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding YMAB
PBA
SI
PCH
Ohio Public Employees Retirement System (OPERS)'s YMAB Position: Q1 2024 in Review
Ohio Public Employees Retirement System (OPERS) sold out of Y-mAbs Therapeutics (YMAB) in Q1 2024, closing a stake of 5,253 shares — an estimated $35.8K sold.
Ohio Public Employees Retirement System (OPERS) first reported a position in YMAB in Q2 2023 and held it in 3 quarters. The position peaked at $123K in Q2 2023. 96 funds tracked by Wall St. Rank hold YMAB as of Q1 2024.
- Ohio Public Employees Retirement System (OPERS) reported no remaining Y-mAbs Therapeutics position as of Q1 2024 after selling out during the quarter.
- Ohio Public Employees Retirement System (OPERS) sold 5,253 Y-mAbs Therapeutics shares in Q1 2024, an estimated $35.8K.
- Ohio Public Employees Retirement System (OPERS) first reported a position in Y-mAbs Therapeutics in Q2 2023 and held it in 3 quarters.
- Ohio Public Employees Retirement System (OPERS)'s Y-mAbs Therapeutics position peaked at $123K in Q2 2023.
- 96 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q1 2024.
Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2024, filed 15 May 2024.